AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC003976.2 | TBC1 domain family member 3B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AC136352.7 | | Predicted secreted proteins
| | | | | Tissue enhanced |
ACPT | Acid phosphatase, testicular | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ACRC | Acidic repeat containing | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AL513478.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Predicted membrane proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALMS1 | Alstrom syndrome 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKEF1 | Ankyrin repeat and EF-hand domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD20A2 | Ankyrin repeat domain 20 family, member A2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD20A4 | Ankyrin repeat domain 20 family, member A4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD30A | Ankyrin repeat domain 30A | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD42 | Ankyrin repeat domain 42 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD53 | Ankyrin repeat domain 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
APITD1-CORT | APITD1-CORT readthrough | Predicted intracellular proteins
| | | | | Tissue enhanced |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ARHGAP28 | Rho GTPase activating protein 28 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP39 | Rho GTPase activating protein 39 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARL9 | ADP-ribosylation factor-like 9 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARMC2 | Armadillo repeat containing 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARMS2 | Age-related maculopathy susceptibility 2 | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ART5 | ADP-ribosyltransferase 5 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASB9 | Ankyrin repeat and SOCS box containing 9 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ASIC3 | Acid-sensing (proton-gated) ion channel 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASRGL1 | Asparaginase like 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ATF7IP2 | Activating transcription factor 7 interacting protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AUNIP | Aurora kinase A and ninein interacting protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
AURKA | Aurora kinase A | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AZIN2 | Antizyme inhibitor 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | Predicted intracellular proteins
| | | | | Tissue enhanced |
BEND4 | BEN domain containing 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BTBD16 | BTB (POZ) domain containing 16 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BX649567.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
C10orf111 | Chromosome 10 open reading frame 111 | Predicted membrane proteins
| | | | | Tissue enhanced |
C10orf131 | Chromosome 10 open reading frame 131 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf25 | Chromosome 10 open reading frame 25 | Predicted secreted proteins
| | | | | Tissue enhanced |
C10orf67 | Chromosome 10 open reading frame 67 | Predicted intracellular proteins
| | | | | Tissue enhanced |